Entry
Name
Oclacitinib (USAN)
Formula
C15H23N5O2S
Exact mass
337.1572
Mol weight
337.44
Structure
Mol file KCF file DB search
Class
Anti-inflammatory
DG01985 Disease modifying anti-rheumatic drug (DMARD)
DG02020 JAK inhibitor
Remark
Efficacy
Antipruritic, Immunosuppressant (veterinary), Janus kinase (JAK) inhibitor
Comment
Treatment of atopic dermatitis and pruritus, veterinary pharmaceutical
Target
Interaction
DDI search
Brite
Drug groups [BR:br08330 ]
Anti-inflammatory
DG01985 Disease modifying anti-rheumatic drug (DMARD)
DG02020 JAK inhibitor
DG02005 Oclacitinib
D10141 Oclacitinib
Target-based classification of drugs [BR:br08310 ]
Protein kinases
Non-receptor tyrosine kinases
JAK family
JAK1
D10141 Oclacitinib (USAN)
Drug groups [BR:br08330 ]
Anti-inflammatory
DG01985 Disease modifying anti-rheumatic drug (DMARD)
DG02020 JAK inhibitor
DG02005 Oclacitinib
BRITE hierarchy
Other DBs
LinkDB
All DBs
KCF data
Show ATOM 23
1 N4x N 23.5900 -31.7800
2 C8x C 23.5900 -33.1800
3 N5x N 24.8024 -33.8800
4 C8y C 26.0149 -33.1800
5 C8y C 26.0149 -31.7800
6 C8y C 24.8024 -31.0800
7 N1c N 24.8024 -29.6802
8 C1y C 23.5732 -28.9703
9 C1a C 25.9980 -28.9898
10 C1x C 23.5735 -27.5801
11 C1x C 22.3612 -26.8799
12 C1y C 21.1486 -27.5796
13 C1x C 21.1483 -28.9698
14 C1x C 22.3606 -29.6701
15 C1b C 19.9300 -26.8757
16 S4a S 18.7307 -27.5680
17 N1b N 17.5456 -26.8835
18 C1a C 16.3529 -27.5719
19 N5x N 27.3464 -33.6126
20 C8x C 28.1693 -32.4800
21 C8x C 27.3464 -31.3474
22 O3c O 18.0307 -28.7804
23 O3c O 19.4307 -28.7804
BOND 25
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 1
5 5 6 2
6 1 6 1
7 6 7 1
8 7 8 1 #Down
9 7 9 1
10 8 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 8 14 1
16 12 15 1 #Up
17 15 16 1
18 16 17 1
19 17 18 1
20 4 19 2
21 19 20 1
22 20 21 2
23 5 21 1
24 16 22 2
25 16 23 2